In the present study, we investigated the value of AUF1 expression level in both cancer cells and stromal fibroblasts as predictive biomarker for clinical outcome of LABC patients following neoadjuvant chemotherapy ± Trastuzumab. Here, HNRNPD is linked to cancer.